Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer’s disease
Year: 2022
Type: article
Abstract: Dysregulation of gene expression in Alzheimer's disease (AD) remains elusive, especially at the cell type level. Gene regulatory network, a key molecular mechanism linking transcription factors (TFs) and regulatory elements to govern gene expression, can change across cell types in the human brain and thus serve as a model for studying gene dysregulation in AD. However, AD-induced regulatory changes across brain cell types remains uncharted. To address this, we integrated single-cell multi-omics datasets to predict the gene regulatory networks of four major cell types, excitatory and inhibitory neurons, microglia and oligodendrocytes, in control and AD brains. Importantly, we analyzed and compared the structural and topological features of networks across cell types and examined changes in AD. Our analysis shows that hub TFs are largely common across cell types and AD-related changes are relatively more prominent in some cell types (e.g., microglia). The regulatory logics of enriched network motifs (e.g., feed-forward loops) further uncover cell type-specific TF-TF cooperativities in gene regulation. The cell type networks are also highly modular and several network modules with cell-type-specific expression changes in AD pathology are enriched with AD-risk genes. The further disease-module-drug association analysis suggests cell-type candidate drugs and their potential target genes. Finally, our network-based machine learning analysis systematically prioritized cell type risk genes likely involved in AD. Our strategy is validated using an independent dataset which showed that top ranked genes can predict clinical phenotypes (e.g., cognitive impairment) of AD with reasonable accuracy. Overall, this single-cell network biology analysis provides a comprehensive map linking genes, regulatory networks, cell types and drug targets and reveals cell-type gene dysregulation in AD.
Source: PLoS Computational Biology
Authors: Chirag Gupta(Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation, Visualization, Writing – original draft, Writing – review & editing), Jielin Xu(Formal analysis, Methodology, Resources, Software, Visualization, Writing – original draft, Writing – review & editing), Ting Jin(Formal analysis, Software), Saniya Khullar(Formal analysis, Software, Visualization, Writing – original draft, Writing – review & editing), Xiaoyu Liu(Formal analysis), Sayali Alatkar(Formal analysis), Feixiong Cheng(Investigation, Methodology, Resources, Supervision, Writing – original draft, Writing – review & editing), Daifeng Wang(Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: Alzheimer's disease, gene regulatory networks, cell type-specific gene regulation, transcription factors, network motifs, feed-forward loop, microglia, excitatory neurons, inhibitory neurons, oligodendrocytes, network modules, drug repurposing, cognitive impairment prediction, single-cell multi-omics
Open Access status: gold
Estimated APC paid: $2,655
Funders: National Science Foundation, University of Wisconsin-Madison, Waisman Center, National Institutes of Health, National Institute on Aging, National Institute of Mental Health, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institute of Child Health and Human Development, Division of Graduate Education, U.S. National Library of Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: Multimodal single-cell genomic and epigenomic analyses elucidate Alzheimer’s sexual dimorphism in human immune systems aging, 1/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders, Determining the neurodevelopmental cell type specific regulatory networks impacted in Down syndrome, Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease, CAREER: Interpretable machine learning deciphers single-cell multi-modal data for understanding cell-type functional genomics in complex brains, A new bladder cancer model based on tissue reprogramming and gene targeting, Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease, G696844456, G7259970065, Creation of a Schwann Cell Gene Regulatory Network, Computation and Informatics in Biology and Medicine, Waisman Center Intellectual and Developmental Disabilities Research Center, TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease, Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
OpenAlex ID: W4285728858
